Medico Intercontinental Limited

BSE: 539938
Medico Intercontinental Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN L24100GJ1984PLC111413 Incorporated 14 August 1984 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - BSE: 539938 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹84.08 Cr
▼ 12.43% YoY
Computed EBITDA · FY 2026
₹4.25 Cr
▼ 51.62% YoY
Net profit · FY 2026
-₹10.98 Cr
▼ 317.12% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹15.5 Cr
Satisfied ₹2.05 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
17
Latest available

About Medico Intercontinental Limited

Data last updated: 25 June 2026

Medico Intercontinental Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 14 August 1984, the company has been in operation for over 42 years.

Registered with ROC Ahmedabad under CIN L24100GJ1984PLC111413. Listed on BSE: 539938.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹10 Cr. Formerly known as Medico Mediserve India Limited and Medico Mediserve Trading Limited. It is led by directors including Tanvi Samirbhai Shah and Samir Dilipkumar Shah.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹84.08 Cr, a decline of 12.43% compared to the previous year. The net worth stands at ₹32.27 Cr (down 33.68% YoY). Total assets are valued at ₹117.26 Cr (up 54.77% YoY).

The company has a workforce of approximately 17 employees as per the latest available data. Its group structure includes 4 subsidiaries.

The company is associated with 1 brand - Medico Intercontinental. As per MCA filings, the company has open charges of ₹15.5 Cr and satisfied charges of ₹2.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicointercontinental.com.

Company Details of Medico Intercontinental Limited
CIN L24100GJ1984PLC111413
Registration Number 111413
Incorporation Date 14 August 1984
ROC Ahmedabad
Listing Status Listed (BSE: 539938)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Dilipkumar Bhogilal Shah Ceo Samir Dilipkumar Shah Managing Director Jay Sharadkumar Shah Cfo
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    medicointercontinental.com
  • Social Media
    Locked
  • Registered Address
    1 – 5Th Floor Adit Raj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Sat, Ellite, Ahmedabad, Gujarat, India – 380015
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Medico Intercontinental Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Medico Intercontinental Limited report

Financials, compliance, directors, charges, ownership and filings for Medico Intercontinental Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Medico Intercontinental Limited

Medico Intercontinental Limited has undergone 3 name changes throughout its history. The company was previously known as Medico Mediserve India Limited, Medico Mediserve Trading Limited, and Intercontinental Leasing And Finance Company Limited. The current legal name is Medico Intercontinental Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Medico Intercontinental Limited Current
Medico Mediserve India Limited Previous
Medico Mediserve Trading Limited Previous
Intercontinental Leasing And Finance Company Limited Previous

CIN History of Medico Intercontinental Limited

Medico Intercontinental Limited has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ1984PLC111413, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24100GJ1984PLC111413 Current
L24100MH1984PLC269707 Previous
L67120DL1984PLC018974 Previous
U67120DL1984PLC018974 Previous
L67120MH1984PLC269707 Previous
L51100MH1984PLC269707 Previous

Associated Brands with Medico Intercontinental Limited

Medico Intercontinental Limited operates one associated brand: Medico Intercontinental. These brands represent Medico Intercontinental Limited's diversified market presence and brand portfolio.

Brand Description Website
Medico Intercontinental
Biopharmaceuticals, health devices, and therapies in healthcare sectors. medicointercontinental.com

Business Activity of Medico Intercontinental Limited

Medico Intercontinental Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Medico Intercontinental Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Medico Intercontinental Limited

Medico Intercontinental Limited is audited by V GOSWAMI & CO (ICAI peer reviewed, certificate valid till 2028-09-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
V GOSWAMI & CO (ICAI peer reviewed, certificate valid till 2028-09-30) FY 2026 Declaration of unmodified opinion

Board of Directors and KMP of Medico Intercontinental Limited

Medico Intercontinental Limited currently reports 6 directors and 2 key managerial personnel. 20 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Tanvi Samirbhai Shah
Also directs: Azillian Healthcare Private Limited, Ritz Formulations Private Limited
Director 14 Aug 2018 8 Years 0 Months Current
Samir Dilipkumar Shah
Also directs: Azillian Healthcare Private Limited, Kings Marvela Llp, Ritz Formulations Private Limited and 5 more
Managing Director 14 Aug 2018 8 Years 0 Months Current
Ankur Amiram Dave
Also directs: Azillian Healthcare Private Limited
Director 23 Mar 2019 7 Years 4 Months Current
Swati Jay Shah Director 29 May 2019 7 Years 2 Months Current
Priyank Lalitbhai Sancheti Director 14 Nov 2022 3 Years 9 Months Current
Dilipkumar Bhogilal Shah
Also directs: Azillian Healthcare Private Limited, Kings Marvela Llp, Ritz Formulations Private Limited and 3 more
Ceo 29 May 2019 7 Years 2 Months Current
Showing 6 of 8 current directors and KMP. View all directors and KMP

Financials of Medico Intercontinental Limited FY 2026 filings available

Medico Intercontinental Limited reported revenue of ₹84.08 Cr (down 12.43% YoY) for FY 2026.

Revenue · FY 2026
₹84.08 Cr ▼ 12.43%
Profit · FY 2026
-₹10.98 Cr ▼ 317.12%
Computed EBITDA · FY 2026
₹4.25 Cr ▼ 51.62%
Revenue₹ Cr · Consolidated050100FY 2019: ₹10 Cr10.3FY 2019FY 2020: ₹82 Cr · +695.6% YoY82+695.6%FY 2020FY 2021: ₹70 Cr · -14.9% YoY69.7-14.9%FY 2021FY 2022: ₹74 Cr · +6.5% YoY74.3+6.5%FY 2022FY 2023: ₹76 Cr · +2.6% YoY76.2+2.6%FY 2023FY 2024: ₹71 Cr · -6.4% YoY71.4-6.4%FY 2024FY 2025: ₹96 Cr · +34.6% YoY96+34.6%FY 2025FY 2026: ₹84 Cr · -12.4% YoY84.1-12.4%FY 2026
Net Profit₹ Cr · Consolidated-15-10-50510FY 2019: ₹1 Cr0.7FY 2019FY 2020: ₹2 Cr · +220.2% YoY2.4+220.2%FY 2020FY 2021: ₹3 Cr · +9.3% YoY2.6+9.3%FY 2021FY 2022: ₹3 Cr · +20.3% YoY3.1+20.3%FY 2022FY 2023: ₹4 Cr · +16.4% YoY3.6+16.4%FY 2023FY 2024: ₹4 Cr · +9.4% YoY3.9+9.4%FY 2024FY 2025: ₹5 Cr · +28.1% YoY5.1+28.1%FY 2025FY 2026: ₹11 Cr (loss) · -317.1% YoY-11FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02040Q1'25: ₹18 Cr18.2Q1'25Q2'25: ₹37 Cr37.2Q2'25Q3'25: ₹19 Cr19.2Q3'25Q4'25: ₹21 Cr21.4Q4'25Q1'26: ₹21 Cr · +17.1% YoY21.4+17.1%Q1'26Q2'26: ₹20 Cr · -45.2% YoY20.4-45.2%Q2'26Q3'26: ₹20 Cr · +3.6% YoY19.8+3.6%Q3'26Q4'26: ₹22 Cr · +5.1% YoY22.5+5.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹84.08 Cr ₹96.02 Cr ₹71.36 Cr ₹76.23 Cr ₹74.26 Cr ₹69.74 Cr ₹81.96 Cr ₹10.3 Cr
Other Income ₹1.27 Cr ₹35.6 Lakh ₹40.14 Lakh ₹51.2 Lakh ₹30.62 Lakh ₹17.84 Lakh ₹5.12 Lakh ₹52,000
Total Income ₹85.35 Cr ₹96.37 Cr ₹71.76 Cr ₹76.74 Cr ₹74.57 Cr ₹69.92 Cr ₹82.01 Cr ₹10.31 Cr
Cost of Materials Consumed ₹7.7 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹53.97 Cr ₹73.41 Cr ₹56.43 Cr ₹63.3 Cr ₹59.61 Cr ₹58.05 Cr ₹75.18 Cr ₹9.53 Cr
Changes in Inventories ₹98.77 Lakh ₹1.2 Cr -₹1.56 Cr -₹99.56 Lakh ₹1.23 Cr -₹43.38 Lakh -₹5.84 Cr -₹63.15 Lakh
Employee Benefit Expense ₹8.77 Cr ₹4.75 Cr ₹3.92 Cr ₹3.22 Cr ₹2.31 Cr ₹2.17 Cr ₹3.22 Cr ₹10.64 Lakh
Finance Costs ₹8.16 Cr ₹99.55 Lakh ₹49.31 Lakh ₹61.86 Lakh ₹87.4 Lakh ₹1.28 Cr ₹1.1 Cr ₹65,000
Depreciation & Amortisation ₹5.43 Cr ₹80.83 Lakh ₹28.67 Lakh ₹20.34 Lakh ₹20.5 Lakh ₹13.74 Lakh ₹10.5 Lakh ₹32,000
Other Expenses ₹9.69 Cr ₹8.24 Cr ₹6.76 Cr ₹5.44 Cr ₹6.11 Cr ₹5.18 Cr ₹5.06 Cr ₹29.07 Lakh
Total Expenses ₹94.69 Cr ₹89.4 Cr ₹66.32 Cr ₹71.79 Cr ₹70.34 Cr ₹66.39 Cr ₹78.81 Cr ₹9.3 Cr
Profit Before Exceptional Items & Tax -₹9.34 Cr ₹6.97 Cr ₹5.44 Cr ₹4.94 Cr ₹4.23 Cr ₹3.53 Cr ₹3.2 Cr ₹1 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹9.34 Cr ₹6.97 Cr ₹5.44 Cr ₹4.94 Cr ₹4.23 Cr ₹3.53 Cr ₹3.2 Cr ₹1 Cr
Total Tax Expense ₹1.75 Cr ₹1.92 Cr ₹1.49 Cr ₹1.34 Cr ₹1.13 Cr ₹95.6 Lakh ₹84.5 Lakh ₹26.87 Lakh
Net Profit -₹10.98 Cr ₹5.06 Cr ₹3.95 Cr ₹3.61 Cr ₹3.1 Cr ₹2.58 Cr ₹2.36 Cr ₹73.6 Lakh
  attributable to Owners -₹3.2 Cr ₹5.06 Cr ₹3.95 Cr ₹3.61 Cr ₹3.1 Cr ₹2.58 Cr ₹2.36 Cr -
  attributable to NCI -₹7.78 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹10.98 Cr ₹5.06 Cr ₹3.95 Cr ₹3.61 Cr ₹3.1 Cr ₹2.58 Cr ₹2.36 Cr ₹73.6 Lakh
EBITDA (computed) ₹4.25 Cr ₹8.78 Cr ₹6.22 Cr ₹5.77 Cr ₹5.31 Cr ₹4.95 Cr ₹4.4 Cr ₹1.01 Cr
Basic EPS ₹-3.20 ₹5.06 ₹3.95 ₹5.61 ₹9.54 ₹7.93 ₹7.25 ₹2.27
Diluted EPS ₹-3.20 ₹5.06 ₹3.95 ₹5.61 ₹9.54 ₹7.93 ₹7.25 ₹2.27
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹117.26 Cr ₹75.76 Cr ₹56.04 Cr ₹58.88 Cr ₹31.94 Cr ₹30.65 Cr ₹38.84 Cr ₹9.33 Cr
Non-current Assets ₹56.01 Cr ₹19.19 Cr ₹17.56 Cr ₹9.18 Cr ₹3.68 Cr ₹2.52 Cr ₹4.81 Cr ₹1.35 Lakh
Current Assets ₹61.25 Cr ₹56.58 Cr ₹38.48 Cr ₹49.7 Cr ₹28.26 Cr ₹28.12 Cr ₹34.02 Cr ₹9.31 Cr
Property, Plant & Equipment ₹36.83 Cr ₹3.62 Cr ₹2.39 Cr ₹1.44 Cr ₹1.22 Cr ₹1.21 Cr ₹1.14 Cr ₹19,000
Inventories ₹14.93 Cr ₹9.24 Cr ₹10.44 Cr ₹8.88 Cr ₹7.88 Cr ₹9.11 Cr ₹8.68 Cr ₹63.15 Lakh
Trade Receivables ₹27.42 Cr ₹32.85 Cr ₹23.21 Cr ₹32.85 Cr ₹17.14 Cr ₹17.98 Cr ₹22.77 Cr ₹6.47 Cr
Cash & Equivalents ₹5.96 Cr ₹2.69 Cr ₹3.37 Cr ₹6.79 Cr ₹1.87 Cr ₹51.48 Lakh ₹77.88 Lakh ₹12.25 Lakh
Equity (Net Worth) ₹32.27 Cr ₹48.65 Cr ₹45.03 Cr ₹41.19 Cr ₹12.64 Cr ₹9.54 Cr ₹9.16 Cr ₹4 Cr
Equity Share Capital ₹10 Cr ₹10 Cr ₹10 Cr ₹10 Cr ₹3.25 Cr ₹3.25 Cr ₹3.25 Cr ₹3.25 Cr
Borrowings (Non-current) ₹46.09 Cr ₹13.47 Cr ₹1.87 Cr ₹2.22 Cr ₹6.25 Cr ₹6.54 Cr ₹13.08 Cr ₹11.21 Lakh
Borrowings (Current) ₹21.04 Cr ₹3.45 Cr ₹2.98 Cr ₹2.5 Cr ₹2.39 Cr ₹2.42 Cr ₹8.18 Lakh ₹0
Total Debt (computed) ₹67.12 Cr ₹16.92 Cr ₹4.85 Cr ₹4.72 Cr ₹8.63 Cr ₹8.96 Cr ₹13.16 Cr ₹11.21 Lakh
Current Liabilities ₹37.74 Cr ₹12.76 Cr ₹8.99 Cr ₹15.36 Cr ₹13.05 Cr ₹14.54 Cr ₹16.58 Cr ₹5.21 Cr
Total Liabilities ₹84.99 Cr ₹27.12 Cr ₹11.01 Cr ₹17.69 Cr ₹19.31 Cr ₹21.11 Cr ₹29.68 Cr ₹5.32 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹17.08 Cr -₹7.11 Cr ₹5.58 Cr -₹10.1 Cr ₹3.85 Cr
Investing Cash Flow ₹2.2 Cr -₹2.19 Cr -₹8.54 Cr -₹5.38 Cr -₹1.3 Cr
Financing Cash Flow -₹15.56 Cr ₹8.63 Cr -₹45.79 Lakh ₹20.41 Cr -₹1.2 Cr
Capital Expenditure ₹4.64 Cr ₹2 Cr ₹1.23 Cr ₹42.18 Lakh ₹21.13 Lakh
Free Cash Flow (computed) ₹12.43 Cr -₹9.11 Cr ₹4.34 Cr -₹10.53 Cr ₹3.64 Cr
Dividends Paid ₹0 ₹0 ₹10 Lakh ₹0 ₹0
Net Change in Cash ₹3.72 Cr -₹67.53 Lakh -₹3.42 Cr ₹4.92 Cr ₹1.35 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹22.49 Cr ₹19.85 Cr ₹20.4 Cr ₹21.35 Cr ₹21.39 Cr ₹19.15 Cr ₹37.24 Cr ₹18.23 Cr
Other Income ₹11.16 Lakh ₹34.17 Lakh ₹55.41 Lakh ₹26.3 Lakh ₹8 Lakh ₹10.8 Lakh ₹4.1 Lakh ₹12.7 Lakh
Total Income ₹22.6 Cr ₹20.19 Cr ₹20.95 Cr ₹21.62 Cr ₹21.47 Cr ₹19.26 Cr ₹37.28 Cr ₹18.36 Cr
Cost of Materials Consumed ₹2.35 Cr ₹1.31 Cr ₹2.42 Cr ₹1.61 Cr ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹12.93 Cr ₹15.29 Cr ₹12.87 Cr ₹12.89 Cr ₹18.32 Cr ₹15.07 Cr ₹26.54 Cr ₹13.47 Cr
Changes in Inventories ₹18.44 Lakh -₹2.25 Cr ₹1.46 Cr ₹1.59 Cr -₹1.41 Cr -₹48.8 Lakh ₹2.32 Cr ₹77.9 Lakh
Employee Benefit Expense ₹2.25 Cr ₹2.37 Cr ₹2.19 Cr ₹1.96 Cr ₹1.45 Cr ₹1.27 Cr ₹1.11 Cr ₹92.45 Lakh
Finance Costs ₹1.85 Cr ₹1.9 Cr ₹2.06 Cr ₹2.36 Cr ₹27.44 Lakh ₹26.18 Lakh ₹28.3 Lakh ₹17.62 Lakh
Depreciation & Amortisation ₹1.43 Cr ₹1.43 Cr ₹1.95 Cr ₹61.87 Lakh ₹28.31 Lakh ₹23.55 Lakh ₹20.74 Lakh ₹8.23 Lakh
Other Expenses ₹3.16 Cr ₹1.54 Cr ₹2.34 Cr ₹2.64 Cr ₹1.03 Cr ₹1.29 Cr ₹4.48 Cr ₹1.44 Cr
Total Expenses ₹24.15 Cr ₹21.59 Cr ₹25.29 Cr ₹23.66 Cr ₹19.95 Cr ₹17.64 Cr ₹34.94 Cr ₹16.87 Cr
Profit Before Exceptional Items & Tax -₹1.55 Cr -₹1.4 Cr -₹4.35 Cr -₹2.04 Cr ₹1.52 Cr ₹1.62 Cr ₹2.34 Cr ₹1.49 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹1.55 Cr -₹1.4 Cr -₹4.35 Cr -₹2.04 Cr ₹1.52 Cr ₹1.62 Cr ₹2.34 Cr ₹1.49 Cr
Total Tax Expense ₹79.83 Lakh ₹28.4 Lakh ₹19.34 Lakh ₹47.49 Lakh ₹35.55 Lakh ₹44.83 Lakh ₹70.53 Lakh ₹40.69 Lakh
Net Profit -₹2.33 Cr -₹1.65 Cr -₹4.51 Cr -₹2.49 Cr ₹1.17 Cr ₹1.17 Cr ₹1.63 Cr ₹1.08 Cr
  attributable to Owners -₹65.31 Lakh -₹21.78 Lakh -₹1.65 Cr -₹67.82 Lakh ₹1.17 Cr ₹1.17 Cr ₹1.63 Cr ₹1.08 Cr
  attributable to NCI -₹1.68 Cr -₹1.44 Cr -₹2.86 Cr -₹1.81 Cr ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹2.33 Cr -₹1.65 Cr -₹4.51 Cr -₹2.49 Cr ₹1.17 Cr ₹1.17 Cr ₹1.63 Cr ₹1.08 Cr
EBITDA (computed) ₹1.72 Cr ₹1.93 Cr -₹33.36 Lakh ₹93.45 Lakh ₹2.08 Cr ₹2.12 Cr ₹2.83 Cr ₹1.75 Cr
Basic EPS ₹-0.65 ₹-0.22 ₹-1.65 ₹-0.68 ₹1.17 ₹1.17 ₹1.63 ₹1.08
Diluted EPS ₹-0.65 ₹-0.22 ₹-1.65 ₹-0.68 ₹1.17 ₹1.17 ₹1.63 ₹1.08
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹54.46 Cr ₹67.13 Cr ₹44.04 Cr ₹48.88 Cr ₹39.25 Cr ₹41.02 Cr ₹46.93 Cr ₹10.3 Cr
Other Income ₹2.35 Cr ₹50.77 Lakh ₹41.66 Lakh ₹34.32 Lakh ₹17.84 Lakh ₹16.43 Lakh ₹2.44 Lakh ₹52,000
Total Income ₹56.81 Cr ₹67.64 Cr ₹44.45 Cr ₹49.23 Cr ₹39.43 Cr ₹41.19 Cr ₹46.96 Cr ₹10.31 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹44.86 Cr ₹54.45 Cr ₹37.46 Cr ₹43.34 Cr ₹32.97 Cr ₹36.78 Cr ₹43.87 Cr ₹9.53 Cr
Changes in Inventories ₹82.69 Lakh ₹1.63 Cr -₹88.16 Lakh -₹1.22 Cr ₹1.09 Cr -₹99.79 Lakh -₹1.93 Cr -₹63.15 Lakh
Employee Benefit Expense ₹2.46 Cr ₹1.74 Cr ₹1.59 Cr ₹1.2 Cr ₹1.03 Cr ₹85.81 Lakh ₹98.59 Lakh ₹10.64 Lakh
Finance Costs ₹1.67 Cr ₹67.22 Lakh ₹22.29 Lakh ₹36.77 Lakh ₹52.14 Lakh ₹77.91 Lakh ₹65.51 Lakh ₹65,000
Depreciation & Amortisation ₹69.35 Lakh ₹55.57 Lakh ₹17.83 Lakh ₹8.66 Lakh ₹10.44 Lakh ₹6.26 Lakh ₹2.45 Lakh ₹32,000
Other Expenses ₹3.18 Cr ₹5.02 Cr ₹3.26 Cr ₹3.08 Cr ₹1.88 Cr ₹2.04 Cr ₹1.81 Cr ₹26.76 Lakh
Total Expenses ₹53.69 Cr ₹64.06 Cr ₹41.83 Cr ₹46.85 Cr ₹37.6 Cr ₹39.53 Cr ₹45.42 Cr ₹9.28 Cr
Profit Before Exceptional Items & Tax ₹3.12 Cr ₹3.58 Cr ₹2.62 Cr ₹2.38 Cr ₹1.83 Cr ₹1.66 Cr ₹1.54 Cr ₹1.03 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹3.12 Cr ₹3.58 Cr ₹2.62 Cr ₹2.38 Cr ₹1.83 Cr ₹1.66 Cr ₹1.54 Cr ₹1.03 Cr
Total Tax Expense ₹93.28 Lakh ₹1.01 Cr ₹72.74 Lakh ₹67.42 Lakh ₹51.6 Lakh ₹46.51 Lakh ₹41.78 Lakh ₹26.87 Lakh
Net Profit ₹2.18 Cr ₹2.57 Cr ₹1.9 Cr ₹1.7 Cr ₹1.31 Cr ₹1.2 Cr ₹1.12 Cr ₹75.91 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹2.18 Cr ₹2.57 Cr ₹1.9 Cr ₹1.7 Cr ₹1.31 Cr ₹1.2 Cr ₹1.12 Cr ₹75.91 Lakh
EBITDA (computed) ₹5.48 Cr ₹4.8 Cr ₹3.03 Cr ₹2.83 Cr ₹2.45 Cr ₹2.5 Cr ₹2.22 Cr ₹1.04 Cr
Basic EPS ₹2.18 ₹2.57 ₹1.90 ₹2.65 ₹4.04 ₹3.68 ₹3.44 ₹2.34
Diluted EPS ₹2.18 ₹2.57 ₹1.90 ₹2.65 ₹4.04 ₹3.68 ₹3.44 ₹2.34
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹67.42 Cr ₹58.77 Cr ₹39.44 Cr ₹44.38 Cr ₹17.72 Cr ₹16.42 Cr ₹19.17 Cr ₹9.32 Cr
Non-current Assets ₹40.26 Cr ₹21.89 Cr ₹17.43 Cr ₹10.63 Cr ₹5.38 Cr ₹4.61 Cr ₹3.7 Cr ₹4.35 Lakh
Current Assets ₹27.16 Cr ₹36.88 Cr ₹22.02 Cr ₹33.75 Cr ₹12.34 Cr ₹11.81 Cr ₹15.47 Cr ₹9.28 Cr
Property, Plant & Equipment ₹1.52 Cr ₹1.68 Cr ₹33.11 Lakh ₹47.64 Lakh ₹19.62 Lakh ₹24.03 Lakh ₹11.82 Lakh ₹19,000
Inventories ₹2.11 Cr ₹2.94 Cr ₹4.57 Cr ₹3.69 Cr ₹2.47 Cr ₹3.56 Cr ₹2.56 Cr ₹63.15 Lakh
Trade Receivables ₹17.93 Cr ₹22.77 Cr ₹14.93 Cr ₹24.92 Cr ₹8.48 Cr ₹8.03 Cr ₹12.67 Cr ₹6.47 Cr
Cash & Equivalents ₹2.16 Cr ₹1.42 Cr ₹2.41 Cr ₹4.95 Cr ₹1.29 Cr ₹11.58 Lakh ₹13.79 Lakh ₹9.12 Lakh
Equity (Net Worth) ₹40.85 Cr ₹38.66 Cr ₹36.1 Cr ₹34.3 Cr ₹7.65 Cr ₹6.34 Cr ₹5.15 Cr ₹4.03 Cr
Equity Share Capital ₹10 Cr ₹10 Cr ₹10 Cr ₹10 Cr ₹3.25 Cr ₹3.25 Cr ₹3.25 Cr ₹3.25 Cr
Borrowings (Non-current) ₹14.97 Cr ₹12.77 Cr ₹79.79 Lakh ₹1.94 Cr ₹5.86 Cr ₹4.78 Cr ₹8.52 Cr ₹9.32 Lakh
Borrowings (Current) ₹1.18 Cr ₹44.53 Lakh ₹16.67 Lakh ₹33.33 Lakh ₹35.08 Lakh ₹3.24 Lakh ₹2.94 Lakh ₹0
Total Debt (computed) ₹16.15 Cr ₹13.22 Cr ₹96.46 Lakh ₹2.27 Cr ₹6.21 Cr ₹4.82 Cr ₹8.55 Cr ₹9.32 Lakh
Current Liabilities ₹11.46 Cr ₹6.95 Cr ₹2.48 Cr ₹8.09 Cr ₹4.21 Cr ₹5.3 Cr ₹5.5 Cr ₹5.2 Cr
Total Liabilities ₹26.57 Cr ₹20.11 Cr ₹3.35 Cr ₹10.08 Cr ₹10.06 Cr ₹10.08 Cr ₹14.03 Cr ₹5.29 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹15.43 Cr -₹6.78 Cr ₹5.73 Cr -₹11.95 Cr ₹1.1 Cr
Investing Cash Flow ₹8.25 Cr -₹4.78 Cr -₹6.65 Cr -₹5.02 Cr -₹79.9 Lakh
Financing Cash Flow -₹22.94 Cr ₹10.57 Cr -₹1.63 Cr ₹20.63 Cr ₹87.15 Lakh
Capital Expenditure ₹41.44 Lakh ₹1.88 Cr ₹3.3 Lakh ₹36.68 Lakh ₹6.03 Lakh
Free Cash Flow (computed) ₹15.02 Cr -₹8.66 Cr ₹5.7 Cr -₹12.32 Cr ₹1.04 Cr
Dividends Paid ₹0 ₹0 ₹10 Lakh ₹0 ₹0
Net Change in Cash ₹74.23 Lakh -₹98.77 Lakh -₹2.54 Cr ₹3.66 Cr ₹1.17 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹15.82 Cr ₹12.75 Cr ₹12.42 Cr ₹13.47 Cr ₹15.24 Cr ₹11.43 Cr ₹28.94 Cr ₹11.52 Cr
Other Income ₹72.97 Lakh ₹79.32 Lakh ₹58.05 Lakh ₹24.18 Lakh ₹13.29 Lakh ₹17.37 Lakh ₹9.79 Lakh ₹10.33 Lakh
Total Income ₹16.55 Cr ₹13.54 Cr ₹13 Cr ₹13.71 Cr ₹15.38 Cr ₹11.6 Cr ₹29.04 Cr ₹11.62 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹13.07 Cr ₹12.02 Cr ₹10.3 Cr ₹9.48 Cr ₹13.97 Cr ₹9.62 Cr ₹21.36 Cr ₹9.5 Cr
Changes in Inventories ₹38.18 Lakh -₹96.97 Lakh ₹12.96 Lakh ₹1.29 Cr -₹81.11 Lakh -₹16.5 Lakh ₹2.12 Cr ₹48.02 Lakh
Employee Benefit Expense ₹66.18 Lakh ₹72.85 Lakh ₹56.13 Lakh ₹50.88 Lakh ₹53.69 Lakh ₹45.41 Lakh ₹37.45 Lakh ₹37.51 Lakh
Finance Costs ₹39.87 Lakh ₹38.53 Lakh ₹44.9 Lakh ₹43.52 Lakh ₹23.1 Lakh ₹16.75 Lakh ₹17.88 Lakh ₹9.49 Lakh
Depreciation & Amortisation ₹15.83 Lakh ₹17.25 Lakh ₹18.71 Lakh ₹17.56 Lakh ₹20.73 Lakh ₹17.29 Lakh ₹14.74 Lakh ₹2.81 Lakh
Other Expenses ₹1.15 Cr ₹36.73 Lakh ₹56.98 Lakh ₹1.09 Cr ₹54.62 Lakh ₹60.25 Lakh ₹3.4 Cr ₹46.46 Lakh
Total Expenses ₹15.82 Cr ₹12.7 Cr ₹12.19 Cr ₹12.97 Cr ₹14.68 Cr ₹10.85 Cr ₹27.59 Cr ₹10.94 Cr
Profit Before Exceptional Items & Tax ₹73.08 Lakh ₹84.34 Lakh ₹80.54 Lakh ₹73.68 Lakh ₹69.4 Lakh ₹75.23 Lakh ₹1.45 Cr ₹68.4 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹73.08 Lakh ₹84.34 Lakh ₹80.54 Lakh ₹73.68 Lakh ₹69.4 Lakh ₹75.23 Lakh ₹1.45 Cr ₹68.4 Lakh
Total Tax Expense ₹30.67 Lakh ₹23.19 Lakh ₹21.35 Lakh ₹18.08 Lakh ₹16.09 Lakh ₹20.57 Lakh ₹45.64 Lakh ₹18.69 Lakh
Net Profit ₹42.41 Lakh ₹61.15 Lakh ₹59.19 Lakh ₹55.6 Lakh ₹53.31 Lakh ₹54.66 Lakh ₹98.89 Lakh ₹49.71 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹42.41 Lakh ₹61.15 Lakh ₹59.19 Lakh ₹55.6 Lakh ₹53.31 Lakh ₹54.66 Lakh ₹98.89 Lakh ₹49.71 Lakh
EBITDA (computed) ₹1.29 Cr ₹1.4 Cr ₹1.44 Cr ₹1.35 Cr ₹1.13 Cr ₹1.09 Cr ₹1.77 Cr ₹80.7 Lakh
Basic EPS ₹0.42 ₹0.61 ₹0.59 ₹0.56 ₹0.53 ₹0.55 ₹0.99 ₹0.50
Diluted EPS ₹0.42 ₹0.61 ₹0.59 ₹0.56 ₹0.53 ₹0.55 ₹0.99 ₹0.50
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Medico Intercontinental Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Medico Intercontinental Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 57.15%, retail and other public shareholders hold 42.85% of Medico Intercontinental Limited. The company had 3,499 shareholders on record.

Promoters: 57.15%Retail & Others: 42.85%
Mar 2026
QUARTER
57.15% Promoters
42.85% Retail & Others
Promoter holding - history
Now 57.15% · Mar 2026High 57.15% · Dec 2025Low 54.78% · Jun 2023
53%54.5%56%57.5%59%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 54.78%Sep 2023: 54.78%Dec 2023: 55.08%Mar 2024: 55.08%Jun 2024: 55.08%Sep 2024: 55.08%Dec 2024: 55.17%Mar 2025: 55.17%Jun 2025: 55.17%Sep 2025: 55.17%Dec 2025: 57.15%Mar 2026: 57.15%57.15%54.78%57.15%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters57.15%57.15%55.17%55.17%55.17%55.17%
Public42.85%42.85%44.83%44.83%44.83%44.83%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters57.15%55.17%55.08%
Public42.85%44.83%44.92%
Promoter change (YoY, %pts)+1.98+0.09-

Group Structure of Medico Intercontinental Limited

Medico Intercontinental Limited has 4 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Medico Intercontinental Limited's business expansion strategy and organizational complexity.

4
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Sungrace Pharma Private Limited U24110GJ2019PTC106267 -
Azillian Healthcare Private Limited U24230GJ2005PTC047259 -
Ritz Formulations Private Limited U24230GJ2019PTC106181 -
Evagrace Pharma Private Limited U51909GJ2018PTC105415 -

Showing major subsidiaries. Total: 4.

Charges & Borrowings of Medico Intercontinental Limited

Open charges
₹15.5 Cr
Satisfied charges
₹2.05 Cr
Breakdown by lending institutions
Standard Chartered Bank₹15.50 Cr
Latest charge details
DateLenderAmountStatus
04 May 2019 Standard Chartered Bank ₹15.5 Cr Open
02 Mar 2021 Others ₹1.05 Cr Satisfied
06 Nov 2020 Standard Chartered Bank ₹1 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Medico Intercontinental Limited

Medico Intercontinental Limited has a workforce of 17 employees as of Sep 26, 2025.

Employee count
17
Active EPFO establishments
1
Employee growth
-15%
Premium access

Employee and EPFO history for Medico Intercontinental Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Medico Intercontinental Limited

Premium access

GST registrations and filing compliance for Medico Intercontinental Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Medico Intercontinental Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Medico Intercontinental Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Medico Intercontinental Limited

Premium access

MSME payment history for Medico Intercontinental Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Medico Intercontinental Limited

Premium access

Corporate group structure for Medico Intercontinental Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Medico Intercontinental Limited

Premium access

MCA filings and documents for Medico Intercontinental Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Medico Intercontinental Limited

Activity
30 Sep 2025
Medico Intercontinental Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Directors
02 Aug 2025
Puneeta Sharma was appointed as a Company Secretary on 02 Aug 2025 & has been associated with this company since 1 year 19 days.
Charges
30 Apr 2025
A charge with Standard Chartered Bank of Rs. 15.50 Cr registered on 04 May 2019 with Charge ID 100263610 was modified on 30 Apr 2025.
Activity
31 Mar 2025
Medico Intercontinental Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
21 Nov 2024
A charge registered on 06 Nov 2020 via Charge ID 100384693 with Standard Chartered Bank was fully satisfied on 21 Nov 2024.
Directors
10 May 2024
Parshwa Kaushal Shah was appointed as a Director on 10 May 2024 & has been associated with this company since 2 years 3 months.

Frequently Asked Questions about Medico Intercontinental Limited

Medico Intercontinental Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 14 August 1984 (42+ years old) and is registered under CIN L24100GJ1984PLC111413. Listed on BSE: 539938. The company has 17 employees.

Medico Intercontinental Limited reported revenue of ₹84.08 Cr for FY 2026 (down 12.43% YoY) based on consolidated BSE filings.

The current directors and KMP of Medico Intercontinental Limited are:

The primary industry of Medico Intercontinental Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Yes. Medico Intercontinental Limited is listed on BSE with code 539938.

Medico Intercontinental Limited can be reached at the registered office: 1 – 5Th Floor Adit Raj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Sat, Ellite, Ahmedabad, Gujarat, India – 380015, or through the website medicointercontinental.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available